ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM
Alʹmanah Kliničeskoj Mediciny. 2016;0(29):33-37 DOI 10.18786/2072-0505-2013-29-33-37
Journal Title: Alʹmanah Kliničeskoj Mediciny
ISSN: 2072-0505 (Print); 2587-9294 (Online)
Publisher: MONIKI
Society/Institution: MONIKI
LCC Subject Category: Medicine
Country of publisher: Russian Federation
Language of fulltext: Russian
Full-text formats available: PDF
AUTHORS
T. A. Мitina
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
A. K. Golenkov
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
A. Yu. Baryshnikov
(Russian Oncologic Research Center n.a. N.N. Blokhin, RAMS RF, Moscow)
A. V. Karaulov
(First Moscow State Medical University n.a. I.M. Sechenov)
E. V. Trifonova
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
Yu. B. Chernykh
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
E. V. Katayeva
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
T. D. Lutskaya
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
L. L. Vysotskaya
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
G. A. Dudina
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
S. G. Zacharov
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
A. M. Fomin
(M.F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI))
N. V. Lyubimova
(Russian Oncologic Research Center n.a. N.N. Blokhin, RAMS RF, Moscow)
I. N. Kogarko
(Research Institute of Chemical Physics n.a. N.N. Semionov, RAS, Moscow)
EDITORIAL INFORMATION
Time From Submission to Publication: 8 weeks
Abstract | Full Text
Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of the residual tumor, detection of the disease course prognosis, and the choice of the optimal approach to the disease therapy.